All FcRn articles
-
NewsScientists launch intranasal albumin-based vaccine technology platform against respiratory virus
A new paper reports on a novel vaccine technology platform, in which the subunit antigen is genetically fused to albumin. The albumin-antigen fusion vaccines induced both systemic and mucosal antigen-specific antibody responses.